ES355853A1 - Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva. - Google Patents

Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.

Info

Publication number
ES355853A1
ES355853A1 ES355853A ES355853A ES355853A1 ES 355853 A1 ES355853 A1 ES 355853A1 ES 355853 A ES355853 A ES 355853A ES 355853 A ES355853 A ES 355853A ES 355853 A1 ES355853 A1 ES 355853A1
Authority
ES
Spain
Prior art keywords
extract
acid
conjugate
pollen extract
naja
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES355853A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES355853A1 publication Critical patent/ES355853A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES355853A 1967-07-07 1968-07-06 Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva. Expired ES355853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31374/67A GB1174854A (en) 1967-07-07 1967-07-07 New Biologically Active Conjugates

Publications (1)

Publication Number Publication Date
ES355853A1 true ES355853A1 (es) 1970-03-01

Family

ID=10322153

Family Applications (1)

Application Number Title Priority Date Filing Date
ES355853A Expired ES355853A1 (es) 1967-07-07 1968-07-06 Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.

Country Status (10)

Country Link
BE (1) BE717689A (enrdf_load_stackoverflow)
CH (1) CH526590A (enrdf_load_stackoverflow)
DE (1) DE1768841C3 (enrdf_load_stackoverflow)
ES (1) ES355853A1 (enrdf_load_stackoverflow)
FR (2) FR1584763A (enrdf_load_stackoverflow)
GB (1) GB1174854A (enrdf_load_stackoverflow)
IL (1) IL30258A (enrdf_load_stackoverflow)
LU (1) LU56423A1 (enrdf_load_stackoverflow)
NL (1) NL160723C (enrdf_load_stackoverflow)
SE (2) SE383100B (enrdf_load_stackoverflow)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003792A (en) 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
GB1243832A (en) * 1968-10-25 1971-08-25 Beecham Group Ltd Vaccines
US3957580A (en) * 1974-03-27 1976-05-18 Pfizer Inc. Immobilized microbial cells
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0128975B1 (en) * 1983-06-15 1987-03-04 Gist-Brocades N.V. Biologically active conjugates and their preparation and use
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
EP0567661A1 (fr) * 1992-04-25 1993-11-03 Societe Des Produits Nestle S.A. Lipase modifiée, procédé de modification et utilisations
DK0567662T3 (da) * 1992-04-25 1997-08-25 Nestle Sa Fremgangsmåde til aromatisering af en mælkechokolade
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
FR2817870B1 (fr) * 2000-12-08 2006-07-28 Skw Nature Products Holding Fr Polymeres conjugues a base de pectines et leur application comme emulsifiants

Also Published As

Publication number Publication date
DE1768841C3 (de) 1980-09-25
CH526590A (de) 1972-08-15
FR1584763A (enrdf_load_stackoverflow) 1970-01-02
NL160723C (nl) 1979-12-17
IL30258A (en) 1972-02-29
LU56423A1 (enrdf_load_stackoverflow) 1968-10-21
NL6809538A (enrdf_load_stackoverflow) 1969-01-09
NL160723B (nl) 1979-07-16
DE1768841B2 (de) 1980-01-31
FR7784M (enrdf_load_stackoverflow) 1970-03-23
DE1768841A1 (de) 1971-11-18
GB1174854A (en) 1969-12-17
SE400652B (sv) 1978-04-03
SE7511288L (sv) 1975-10-08
SE383100B (sv) 1976-03-01
BE717689A (enrdf_load_stackoverflow) 1968-12-16

Similar Documents

Publication Publication Date Title
ES355853A1 (es) Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.
US4003792A (en) Conjugates of acid polysaccharides and complex organic substances
Henrici An endotoxin from Aspergillus fumigatus
DE69618018T2 (de) Arzneimittel enthaltend botulinum toxin oder neurotoxin und herstellungsverfahren
US20120014991A1 (en) Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
US4372883A (en) Process for the production of vaccine
DK0388954T3 (da) Frysetørrede polymerdispersioner og anvendelsen deraf til fremstilling af farmaceutiske præparater m ed langvarig frigivelse
AU740784B2 (en) Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
ES2053575T3 (es) Lipasas y extractos lipasicos, su procedimiento de preparacion y su aplicacion en terapeutica.
US5460832A (en) Skin cosmetic having an egg white enzyme hydrolysate with hyaluronic acid synthesis promoting activity
Chetty et al. Soluble peptidoglycan-polysaccharide fragments of the bacterial cell wall induce acute inflammation
Lambden et al. Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolyasaccharide of Neisseria Gonorrhoeae P9
US3577523A (en) Water-insoluble antigenic substances and method of preparing the same and antigenic depot agents incorporating such substances
US4432969A (en) Pharmaceutical compositions
ATE98869T1 (de) Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.
EP0367306A2 (en) Procedure for polymerized allergenis production
DK0421949T3 (da) Kemisk modificerede allergener og fremgangsmåde til deres fremstilling
JP2000507252A (ja) 免疫性物質を産生する方法及びワクチン
GB931016A (en) Amino acids concentrate and intravenous preparations thereof
JPS5634694A (en) Water-soluble cultivation extract of nonpathogenic aerobic corynebacterium having immunological activity, its preparation, and pharmaceutical preparation
Ottaviano et al. Trichophytin extraction: biological comparison of trichophytin extracted from Trichophyton mentagrophytes grown in a complex medium and a defined medium
RU2122862C1 (ru) Бесклеточная антистафилококковая вакцина для лечения хронической стафилококковой инфекции
Peeters et al. Polysaccharicb-conjugate vaccines
SU1580617A1 (ru) Способ получения вакцины против вируса гриппа
Seiler et al. BCG versus VCN: The antigenicity and the adjuvant effect of both compounds